For the third quarter of the fiscal year, Hillrom reported earnings of $1.40 consistent with a consistent diluted percentage compared to $0.48 consistent with a consistent percentage diluted in the previous year. On an adjusted basis, special items, gains of $1.95 consistent with a consistent diluted percentage greater than 59% of $1.23 consistent with a consistent percentage diluted in the last year. The monetary effects of the third quarter reflect strong revenues that benefited from COVID-related purchases, strategic investments to drive long-term growth, rigorous charge control, and margin expansion. The adjustments to the reported earnings are detailed in the reconciliation tables provided.
“I would like to congratulate the determination and contributions of the entire Hillrom team on their regular efforts to provide critical products and responses in reaction to the COVID-19 pandemic. Their responsiveness helped generate record monetary functionality in the fiscal third quarter,” said John Groetelaars, President and CEO of Hillrom. “We remain confident in the compelling pricing proposals of our products, the basics and sustainability of our various expansion platforms as we continue to browse the dubious business and healthcare environment. Hillrom’s vision of Advancing Connected Care ™ has become more important as we change our customers’ changing desires.”